No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Aclarion Inc - Nociscan Now Available in Louisiana Through Sil Agreement
Express News | Aclarion Announces Commercial Agreement With Spine Institute of Louisiana
Express News | Aclarion Inc Files for Mixed Shelf of up to $150 Mln – SEC Filing
Aclarion Releases Updated Investor Presentation at Showcase
Aclarion's AI-Powered Nociscan Proves More Cost-Effective for Chronic Back Pain Diagnosis
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis